MUSTANG BIO INC's ticker is MBIO and the CUSIP is 62818Q104. A total of 99 filers reported holding MUSTANG BIO INC in Q4 2020. The put-call ratio across all filers is 0.92 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $15,000 | -21.1% | 31,286 | 0.0% | 0.00% | – |
Q2 2022 | $19,000 | -90.4% | 31,286 | -84.0% | 0.00% | – |
Q1 2022 | $198,000 | -39.3% | 195,903 | 0.0% | 0.00% | – |
Q4 2021 | $326,000 | -32.4% | 195,903 | +9.5% | 0.00% | – |
Q3 2021 | $482,000 | -18.9% | 178,853 | 0.0% | 0.00% | – |
Q2 2021 | $594,000 | +51.9% | 178,853 | +52.0% | 0.00% | – |
Q1 2021 | $391,000 | -12.3% | 117,669 | 0.0% | 0.00% | – |
Q4 2020 | $446,000 | +100.9% | 117,669 | +67.6% | 0.00% | – |
Q3 2020 | $222,000 | -8.6% | 70,208 | -8.0% | 0.00% | – |
Q2 2020 | $243,000 | +28.6% | 76,291 | +8.3% | 0.00% | – |
Q1 2020 | $189,000 | -34.4% | 70,414 | 0.0% | 0.00% | – |
Q4 2019 | $288,000 | +25.2% | 70,414 | 0.0% | 0.00% | – |
Q3 2019 | $230,000 | -11.5% | 70,414 | 0.0% | 0.00% | – |
Q2 2019 | $260,000 | +73.3% | 70,414 | +60.8% | 0.00% | – |
Q1 2019 | $150,000 | +61.3% | 43,779 | +39.9% | 0.00% | – |
Q4 2018 | $93,000 | -50.3% | 31,300 | 0.0% | 0.00% | – |
Q3 2018 | $187,000 | -13.4% | 31,300 | 0.0% | 0.00% | – |
Q2 2018 | $216,000 | – | 31,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Telemetry Investments, L.L.C. | 297,500 | $300,000 | 0.47% |
GSA CAPITAL PARTNERS LLP | 1,216,445 | $1,229,000 | 0.16% |
Ikarian Capital, LLC | 546,824 | $551,000 | 0.07% |
Sassicaia Capital Advisers LLC | 12,000 | $12,000 | 0.06% |
EMFO, LLC | 32,000 | $32,000 | 0.03% |
B. Riley Wealth Advisors, Inc. | 310,926 | $315,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 312,800 | $316,000 | 0.01% |
Renaissance Technologies | 2,449,100 | $2,474,000 | 0.00% |
Arete Wealth Advisors, LLC | 15,538 | $16,000 | 0.00% |
Herold Advisors, Inc. | 4,000 | $4,040,000 | 0.00% |